<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01854879</url>
  </required_header>
  <id_info>
    <org_study_id>CT004</org_study_id>
    <nct_id>NCT01854879</nct_id>
  </id_info>
  <brief_title>Evaluation of Nucleus 6 Sound Coding Algorithms</brief_title>
  <official_title>Evaluation of Nucleus 6 Sound Coding Algorithms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cochlear</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study was to evaluate the features of the Nucleus 6 Sound Processor (CP900&#xD;
      series) on existing Nucleus recipients who currently use the previous generation sound&#xD;
      processor, the Cochlear Nucleus CP810 (also commonly known as the Nucleus 5), with a Cochlear&#xD;
      Nucleus CI24RE, CI512 or CI422 cochlear implant. The features evaluated included an enhanced&#xD;
      Automatic Gain Control (eAGC), the option to provide acoustic amplification in combination&#xD;
      with traditional electric stimulation through an acoustic component, and three input&#xD;
      processing algorithms: Signal to Noise Ratio - Noise Canceller (SNR-NC), Wind Noise Reduction&#xD;
      (WNR) and Automatic Scene Analyzer (SCAN).&#xD;
&#xD;
      As is customary for a single-subject research design, study results will be analyzed for each&#xD;
      subject individually. For evaluations where testing took place under two conditions (i.e.&#xD;
      Endpoint 2, 3, 4, and 5) a non-inferiority hypothesis test based on the paired comparisons of&#xD;
      the % of words correct will be performed. For each subject, the paired difference (P1 minus&#xD;
      P2) will be calculated and the mean difference will be tested statistically against a&#xD;
      non-inferiority null hypothesis of 10%. Successful rejection of the null hypothesis allows&#xD;
      for a conclusion that the performance under the test condition 2 (based on the Nucleus 6&#xD;
      sound processor) will be non-inferior to the test condition 1 (based on the Nucleus 5 sound&#xD;
      processor).&#xD;
&#xD;
      Ho: P1 - P2 â‰¥ 10% Ha: P1 - P2 &lt; 10%&#xD;
&#xD;
      We hypothesize acceptance of the null hypothesis for the Nucleus 6 features.&#xD;
&#xD;
      Testing will be based on a paired t-test with a one-sided 0.05 alpha level. The value of 10%&#xD;
      was selected as the non-inferiority margin as one that can be tested with reasonable power&#xD;
      and was clinically meaningful.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Words Correct on AzBio Sentences in Noise S0N90</measure>
    <time_frame>Each assessment was completed acutely which equated to approximately 2 hours of testing</time_frame>
    <description>Individuals were tested with AzBio Sentences in Noise using a speech front (0 degrees) and noise presented to the implant ear (90 degrees) using the following features: enhanced Automatic Gain Control (eAGC), Signal to Noise Ratio - Noise Canceller (SNR-NC), Wind Noise Reduction (WNR) and Automatic Scene Analyzer (SCAN).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">97</enrollment>
  <condition>Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Nucleus 6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nucleus 6 sound processor</intervention_name>
    <arm_group_label>Nucleus 6</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Eight years of age or older&#xD;
&#xD;
          2. CI24RE, CI500 or CI422 series Nucleus cochlear implant types (commercially approved)&#xD;
&#xD;
          3. At least 3 months experience with the cochlear implant&#xD;
&#xD;
          4. Post-linguistic onset of bilateral sensorineural hearing loss, with no congenital&#xD;
             component to the hearing loss&#xD;
&#xD;
          5. Native speaker of English, the language used to assess speech perception performance&#xD;
&#xD;
          6. Willingness to participate in and to comply with all requirements of the protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. Unrealistic expectations on the part of the subject, regarding the possible benefits,&#xD;
        risks, and limitations that are inherent to the prosthetic device 2. Unwillingness or&#xD;
        inability of the candidate to comply with all investigational requirements 3. Additional&#xD;
        handicaps that would prevent or restrict participation in the audiological evaluations&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 13, 2013</study_first_submitted>
  <study_first_submitted_qc>May 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2013</study_first_posted>
  <results_first_submitted>October 14, 2020</results_first_submitted>
  <results_first_submitted_qc>October 14, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 4, 2020</results_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>background noise</keyword>
  <keyword>speech performance</keyword>
  <keyword>wind noise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Nucleus 6</title>
          <description>Nucleus 6 sound processor</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="97">97 consented</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="92">92 had matched endpoint data</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Could not complete testing within the scheduled time.</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>screen fail</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>incomplete data set</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Nucleus 6</title>
          <description>Nucleus 6 sound processor</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="92"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.4" spread="21.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Words Correct on AzBio Sentences in Noise S0N90</title>
        <description>Individuals were tested with AzBio Sentences in Noise using a speech front (0 degrees) and noise presented to the implant ear (90 degrees) using the following features: enhanced Automatic Gain Control (eAGC), Signal to Noise Ratio - Noise Canceller (SNR-NC), Wind Noise Reduction (WNR) and Automatic Scene Analyzer (SCAN).</description>
        <time_frame>Each assessment was completed acutely which equated to approximately 2 hours of testing</time_frame>
        <population>subjects enrolled who met candidacy criteria that had paired results for endpoint testing</population>
        <group_list>
          <group group_id="O1">
            <title>Nucleus 6</title>
            <description>Nucleus 6 sound processor</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Words Correct on AzBio Sentences in Noise S0N90</title>
          <description>Individuals were tested with AzBio Sentences in Noise using a speech front (0 degrees) and noise presented to the implant ear (90 degrees) using the following features: enhanced Automatic Gain Control (eAGC), Signal to Noise Ratio - Noise Canceller (SNR-NC), Wind Noise Reduction (WNR) and Automatic Scene Analyzer (SCAN).</description>
          <population>subjects enrolled who met candidacy criteria that had paired results for endpoint testing</population>
          <units>percentage of words correct</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="92"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.1" spread="13.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 day - study was conducted acutely</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Nucleus 6</title>
          <description>Nucleus 6 sound processor</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="92"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="92"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lori O'Neill Director of Research</name_or_title>
      <organization>Cochlear Americas</organization>
      <phone>(303) 790-9010</phone>
      <email>loneill@cochlear.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

